Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ripasudil Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116143713A reveals a novel 4-step route for 1,4-diazepane derivatives, offering high purity, reduced toxicity, and scalable manufacturing for ROCK inhibitor intermediates.
Novel patent CN118580192B details efficient chiral intermediate synthesis. Offers cost reduction and supply reliability for pharmaceutical manufacturing partners globally.